Status:
COMPLETED
Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.
Lead Sponsor:
University of Copenhagen
Collaborating Sponsors:
Lundbeck Foundation
Arla Foods
Conditions:
Obesity
Insulin Resistance
Eligibility:
FEMALE
40-70 years
Phase:
NA
Brief Summary
Studies of the human gut microbiome have suggested that treatment or prevention aimed at the obese microbiome could influence the development of obesity-associated metabolic disturbances. The objecti...
Eligibility Criteria
Inclusion
- Post-menopausal
- BMI between 30-45 kg/m2
- Waist circumference \> 80 cm
- High leukocyte count
Exclusion
- Medically-treated Type 2 diabetes or dyslipidaemia
- Use of antibiotics during the last 3 months
- Use of pro- or prebiotic supplements during the last 6 weeks
- Illnesses related to the gastro-intestinal tract
- History of psychiatric diseases (incl. depression)
- Liver disease
- Alcohol abuse
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT01433120
Start Date
September 1 2011
End Date
August 1 2013
Last Update
June 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen
Frederiksberg C, Denmark, 1958